Refine
Year of publication
Document Type
- Preprint (660)
- Article (442)
- Conference Proceeding (1)
- Working Paper (1)
Language
- English (1104) (remove)
Has Fulltext
- yes (1104)
Is part of the Bibliography
- no (1104)
Keywords
- Heavy Ion Experiments (20)
- Hadron-Hadron Scattering (11)
- Hadron-Hadron scattering (experiments) (11)
- LHC (9)
- SARS-CoV-2 (8)
- Heavy-ion collision (6)
- COVID19-NMR (5)
- ALICE experiment (4)
- Collective Flow (4)
- Jets (4)
- Quark-Gluon Plasma (4)
- Solution NMR spectroscopy (4)
- 5′-UTR (3)
- ALICE (3)
- Heavy Ions (3)
- Jets and Jet Substructure (3)
- RNA (3)
- pp collisions (3)
- ACLF (2)
- BCR/ABL (2)
- Beauty production (2)
- Charm physics (2)
- Epilepsy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Heavy Quark Production (2)
- Lepton-Nucleon Scattering (experiments) (2)
- NMR spectroscopy (2)
- Non-structural protein (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- Philadelphia chromosome (2)
- QCD (2)
- Seizure (2)
- Single electrons (2)
- Solution NMR-spectroscopy (2)
- acute-on-chronic liver failure (2)
- glioblastoma (2)
- proteomics (2)
- radiotherapy (2)
- 19F (1)
- 2-deoxyglucose (2-DG) (1)
- 5'-UTR (1)
- 5_SL4 (1)
- 900 GeV (1)
- ALICE detector (1)
- ALK-rearranged NSCLC (1)
- Abl kinase inhibitors (1)
- Active middle ear implants (1)
- Allosteric inhibition (1)
- Alternating Phase Focusing (1)
- Angiomyolipoma (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Anticonvulsant (1)
- Auditory system (1)
- Autologous stem cell transplantation (1)
- B cell receptor (1)
- B. subtilis (1)
- Bartonella grahamii (1)
- Bartonella henselae (1)
- Bartonella schoenbuchensis (1)
- Beam dynamics simulation (1)
- Beskid Niski Mts (1)
- Biogeochemistry (1)
- Biomarker (1)
- Bone conduction devices (1)
- Boosted Jets (1)
- Brain tumor (1)
- Business strategy in drug development (1)
- CAKUT (1)
- CLIF-C ACLF score (1)
- CLIF-C ACLF-R score (1)
- COVID-19 (1)
- CPTAC (1)
- CRC65 (1)
- Carbon cycle (1)
- Cementation (1)
- Centrality Class (1)
- Centrality Selection (1)
- Ceramic (1)
- Chemical communication (1)
- Chocó rainforest (1)
- Chronic disease (1)
- Collective Flow, (1)
- Communication center (1)
- Comparative genomics (1)
- Comparison with QCD (1)
- Consensus statement (1)
- Continuous wave (1)
- Core marking (1)
- Costs (1)
- Covid19-NMR (1)
- Covid19-nmr (1)
- DNA-PAINT (1)
- Data sharing (1)
- Depression (1)
- Diagnostic imaging (1)
- Drug screens (1)
- Drug therapy (1)
- E. coli (1)
- Ecosystem ecology (1)
- Ecuador (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Everolimus (1)
- Evolution (1)
- FBS (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Forest ecology (1)
- Functionally-impaired elderly (1)
- Fungi (1)
- Gene expression profiling (1)
- General practice (1)
- Genetics (1)
- Glioma (1)
- HBT (1)
- HOD (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hard Scattering (1)
- Health policy (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ion (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Hematology (1)
- High-dose chemotherapy (1)
- High-throughput screening (1)
- Holmes tremor (1)
- Hyperons (1)
- Immunology (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Invertebrates (1)
- Ionisation energy loss (1)
- Ixodes ricinus (1)
- Jet Physics (1)
- Jet Substructure (1)
- Lenalidomide (1)
- Leukemias (1)
- Linear accelerator (1)
- Localized defecation (1)
- MTOR inhibitor (1)
- Macrodomain (1)
- Magnetic resonance imaging (1)
- Material budget (1)
- Meriç River (1)
- Microplastic (1)
- Mid-rapidity (1)
- Minimal invasive (1)
- Minimum Bias (1)
- Mixed hearing loss (1)
- Mixture toxicity (1)
- Molecular biology (1)
- Molecular matched therapy (1)
- Molecular medicine (1)
- Molecular modelling (1)
- Molecular profiling (1)
- Molecular therapy (1)
- Mollusks (1)
- Monolithic crown (1)
- Monte Carlo (1)
- Multi-Parton Interactions (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multiple myeloma (1)
- Multiple stressors (1)
- NAFL (1)
- NASH (1)
- Neural network (1)
- Neuroscience (1)
- Non-small cell lung cancer (1)
- Nonlinear beam dynamics (1)
- Nuclear modification factor (1)
- Nucleus (1)
- Oncology (1)
- Osimertinib (1)
- PYTHIA (1)
- Pain (1)
- Particle and Resonance Production (1)
- Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (1)
- Pb–Pb (1)
- Physiology (1)
- Plant symbiosis (1)
- Pond snail (1)
- Positron emission tomography (1)
- Production Cross Section (1)
- Properties of Hadrons (1)
- Protein drugability (1)
- Proteins (1)
- Proton (1)
- Proton–proton (1)
- Psychiatric disorders (1)
- Quality of life (1)
- Quark Deconfinement (1)
- Quark Gluon Plasma (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quarkonium (1)
- RNA genome (1)
- RNASolution-state NMR (1)
- RSL curve (1)
- Rapidity Range (1)
- Rehabilitation (1)
- Relapse (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Resolution Parameter (1)
- Rhabdomyoma (1)
- SL1 (1)
- SL5a (1)
- SL5b (1)
- SL5b + c (1)
- SL5c (1)
- SLC20A1 (1)
- SPSS (1)
- Second-line treatment (1)
- Self-assessment (1)
- Single muons (1)
- Sociodemographic characteristics (1)
- Strangeness (1)
- Subependymal giant cell astrocytoma (1)
- Surgery (1)
- Systematic Uncertainty (1)
- TP53 mutation status (1)
- TR (1)
- TSC (1)
- Target validation (1)
- Targeted therapy (1)
- Technical data (1)
- Tet-inducible system (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Urban ecology (1)
- Vasculitis (1)
- Vector Boson Production (1)
- Warburg effect (1)
- Xenon-based gas mixture (1)
- Zirconia (1)
- aboveground biomass (1)
- accessory proteins (1)
- acute coronary syndrome (1)
- acute decompensation (1)
- acute lymphatic leukemia (1)
- adult (1)
- aegean (1)
- aging (1)
- allosteric inhibition (1)
- amplicon sequencing (1)
- antisynthetase antibodies (1)
- antisynthetase syndrome (1)
- archeological sea-level limiting points (1)
- arthritis (1)
- artifacts (1)
- artificial feeding (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- biochemistry (1)
- biodiversity (1)
- biophysics (1)
- bipartite networks (1)
- bladder exstrophy-epispadias complex (1)
- cancer (1)
- cannabidiol (1)
- cannabinoids (1)
- cannabis (1)
- cell-free protein synthesis (1)
- cerebrospinal fluid (1)
- chemotherapy (1)
- chronosequence (1)
- cirrhosis (1)
- clinical trial (1)
- cloacal malformation (1)
- coastal geomorphology (1)
- computed tomography (1)
- copeptin (1)
- dE/dx (1)
- data quality (1)
- deadwood (1)
- decomposition (1)
- detector (1)
- diffusion-weighted magnetic resonance imaging (1)
- doxycycline (1)
- drug response (1)
- dysbiosis (1)
- ectosomes (1)
- electrical resistivity tomography (1)
- electroencephalography (EEG) (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- females (1)
- fluorine (1)
- folding (1)
- foraminifera (1)
- foraminifers (1)
- fragment screening (1)
- fragment-based screening (1)
- functional genetics (1)
- geophysical prospections (1)
- global change (1)
- glycolysis (1)
- guidelines (1)
- habitat destruction (1)
- head-and-neck cancer (1)
- healthy subjects (1)
- heavy ion experiments (1)
- hepatic encephalopathy (1)
- hypoxia-induced cell death (1)
- immunotherapy (1)
- inducible gene expression (1)
- inflammation (1)
- interferon gamma (1)
- interstitial lung disease (1)
- intrinsically disordered region (1)
- isocaloric ketogenic diet (1)
- kidney formation (1)
- kinetics (1)
- land use (1)
- lichen diversity (1)
- lichenized fungi (1)
- liver (1)
- lung cancer (1)
- mTOR inhibitor (1)
- magnetic gradiometry (1)
- magnetic resonance imaging (1)
- mechanical ventilation (1)
- medulloblastoma (1)
- medulloblastoma resection (1)
- meta-stable structures (1)
- metabolic cancer therapy (1)
- metabolic syndromes (1)
- metastasis (1)
- microbes (1)
- microbiome (1)
- micropalaeontology (1)
- microparticles (1)
- microvesicles (1)
- minimal information requirements (1)
- mitochondria (1)
- model psychosis (1)
- modularity (1)
- molecular therapy (1)
- mortality (1)
- multicenter study (1)
- multiplexed immunofluorescence (1)
- myocardial infarction (1)
- myositis (1)
- myxomycete (1)
- neoadjuvant chemoradiotherapy (1)
- neoepitopes (1)
- neurodegeneration (1)
- new records (1)
- newly diagnosed glioblastoma (1)
- nivolumab (1)
- nonstructural proteins (1)
- nymphs (1)
- oral cavity cancer (1)
- palatal tremor (1)
- patient stratification (1)
- portal hypertension (1)
- portosystemic shunt (1)
- posterior fossa masses (1)
- predictive biomarker (1)
- proteins (1)
- pulmonary failure (1)
- quark gluon plasma (1)
- randomized (1)
- rare species (1)
- rct (1)
- reassembly (1)
- registry (1)
- reproducibility (1)
- resilience (1)
- resistance (1)
- respiratory failure (1)
- riboswitches (1)
- rigor (1)
- saprotrophic fungi (1)
- sea-level indicator (1)
- sequential ALK-inhibitor therapy (1)
- specialization (1)
- spectra (1)
- spontaneous portosystemic shunt (1)
- standardization (1)
- structural biology (1)
- structural proteins (1)
- subgrouping (1)
- targeted therapy (1)
- temozolomide (1)
- tetracycline (1)
- tetrahydrocannabinol (1)
- transcription (1)
- transovarial transmission (1)
- transstadial transmission (1)
- trees (1)
- troponin (1)
- tumor metabolism (1)
- tumor-infiltrating lymphocytes (1)
- unmethylated MGMT (1)
- urinary tract development (1)
- vector (1)
- zebrafish development (1)
- “gatekeeper” mutation T315I (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1024)
- Frankfurt Institute for Advanced Studies (FIAS) (947)
- Informatik (914)
- Medizin (49)
- Biowissenschaften (12)
- Biochemie, Chemie und Pharmazie (10)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (9)
- Geowissenschaften (4)
- Biodiversität und Klima Forschungszentrum (BiK-F) (3)
- Georg-Speyer-Haus (3)
Neoepitope-specific T-cell responses have been shown to induce durable clinical responses in patients with advanced cancers. We explored the recognition patterns of tumor-infiltrating T lymphocytes (TILs) from patients with glioblastoma multiforme (GBM), the most fatal form of tumors of the central nervous system. Whole-genome sequencing was used for generating DNA sequences representing the entire spectrum of ‘private’ somatic mutations in GBM tumors from five patients, followed by 15-mer peptide prediction and subsequent peptide synthesis. For each mutated peptide sequence, the wildtype sequence was also synthesized and individually co-cultured with autologous GBM TILs, which had been expanded in vitro with a combination of interleukin (IL)-2, IL-15 and IL-21. After seven days of culture, interferon gamma (IFN-γ), tumor necrosis factor alpha (TNF-α) and/or IL-17A production was measured by ELISA in culture supernatants, and used as an epitope-specific immune response readout. Mutated peptides that induced a strong cytokine response were considered to contain legitimate neoepitopes. TILs from 5/5 patients with GBM exhibited specific immune reactivity profiles to the nominal target peptides, defined by IFN-γ and/or TNF-α production, as well as IL-17A. Neoepitopes, defined by mutated peptides inducing IFN-γ and/or TNF-α production without or only minimal reactivity to the wildtype sequences, were found for each individual patient. CD8+ TILs dominated the patients’ responses to private neoepitopes. The present study shows that neoepitope-specific TIL reactivity constitutes an important arm of anti-tumor immune responses in patients with GBM, and thus a powerful tool for developing next-generation personalized immunotherapies.
Obsessive-compulsive disorder (OCD) is a common neuropsychiatric disease affecting about 2% of the general population. It is characterized by persistent intrusive thoughts and repetitive ritualized behaviors. While gene variations, malfunction of cortico-striato-thalamo-cortical (CSTC) circuits, and dysregulated synaptic transmission have been implicated in the pathogenesis of OCD, the underlying mechanisms remain largely unknown. Here we show that OCD-like behavior in mice is caused by deficiency of SPRED2, a protein expressed in various brain regions and a potent inhibitor of Ras/ERK-MAPK signaling. Excessive self-grooming, reflecting OCD-like behavior in rodents, resulted in facial skin lesions in SPRED2 knockout (KO) mice. This was alleviated by treatment with the selective serotonin reuptake inhibitor fluoxetine. In addition to the previously suggested involvement of cortico-striatal circuits, electrophysiological measurements revealed altered transmission at thalamo-amygdala synapses and morphological differences in lateral amygdala neurons of SPRED2 KO mice. Changes in synaptic function were accompanied by dysregulated expression of various pre- and postsynaptic proteins in the amygdala. This was a result of altered gene transcription and triggered upstream by upregulated tropomyosin receptor kinase B (TrkB)/ERK-MAPK signaling in the amygdala of SPRED2 KO mice. Pathway overactivation was mediated by increased activity of TrkB, Ras, and ERK as a specific result of SPRED2 deficiency and not elicited by elevated brain-derived neurotrophic factor levels. Using the MEK inhibitor selumetinib, we suppressed TrkB/ERK-MAPK pathway activity in vivo and reduced OCD-like grooming in SPRED2 KO mice. Altogether, this study identifies SPRED2 as a promising new regulator, TrkB/ERK-MAPK signaling as a novel mediating mechanism, and thalamo-amygdala synapses as critical circuitry involved in the pathogenesis of OCD.
Introduction: Evidence from a number of open-label, uncontrolled studies has suggested that rituximab may benefit patients with autoimmune diseases who are refractory to standard-of-care. The objective of this study was to evaluate the safety and clinical outcomes of rituximab in several standard-of-care-refractory autoimmune diseases (within rheumatology, nephrology, dermatology and neurology) other than rheumatoid arthritis or non-Hodgkin's lymphoma in a real-life clinical setting.
Methods: Patients who received rituximab having shown an inadequate response to standard-of-care had their safety and clinical outcomes data retrospectively analysed as part of the German Registry of Autoimmune Diseases. The main outcome measures were safety and clinical response, as judged at the discretion of the investigators.
Results: A total of 370 patients (299 patient-years) with various autoimmune diseases (23.0% with systemic lupus erythematosus, 15.7% antineutrophil cytoplasmic antibody-associated granulomatous vasculitides, 15.1% multiple sclerosis and 10.0% pemphigus) from 42 centres received a mean dose of 2,440 mg of rituximab over a median (range) of 194 (180 to 1,407) days. The overall rate of serious infections was 5.3 per 100 patient-years during rituximab therapy. Opportunistic infections were infrequent across the whole study population, and mostly occurred in patients with systemic lupus erythematosus. There were 11 deaths (3.0% of patients) after rituximab treatment (mean 11.6 months after first infusion, range 0.8 to 31.3 months), with most of the deaths caused by infections. Overall (n = 293), 13.3% of patients showed no response, 45.1% showed a partial response and 41.6% showed a complete response. Responses were also reflected by reduced use of glucocorticoids and various immunosuppressives during rituximab therapy and follow-up compared with before rituximab. Rituximab generally had a positive effect on patient well-being (physician's visual analogue scale; mean improvement from baseline of 12.1 mm).
Conclusions: Data from this registry indicate that rituximab is a commonly employed, well-tolerated therapy with potential beneficial effects in standard of care-refractory autoimmune diseases, and support the results from other open-label, uncontrolled studies.
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures, called exosomes, microvesicles, microparticles, ectosomes, oncosomes, apoptotic bodies, and many other names. However, specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly. The International Society for Extracellular Vesicles (ISEV) proposed Minimal Information for Studies of Extracellular Vesicles (“MISEV”) guidelines for the field in 2014. We now update these “MISEV2014” guidelines based on evolution of the collective knowledge in the last four years. An important point to consider is that ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation. For example, claims that exosomes are endowed with exquisite and specific activities remain difficult to support experimentally, given our still limited knowledge of their specific molecular machineries of biogenesis and release, as compared with other biophysically similar EVs. The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities. Finally, a checklist is provided with summaries of key points.
In bacteria, the regulation of gene expression by cis-acting transcriptional riboswitches located in the 5'-untranslated regions of messenger RNA requires the temporal synchronization of RNA synthesis and ligand binding-dependent conformational refolding. Ligand binding to the aptamer domain of the riboswitch induces premature termination of the mRNA synthesis of ligand-associated genes due to the coupled formation of 3'-structural elements acting as terminators. To date, there has been no high resolution structural description of the concerted process of synthesis and ligand-induced restructuring of the regulatory RNA element. Here, we show that for the guanine-sensing xpt-pbuX riboswitch from Bacillus subtilis, the conformation of the full-length transcripts is static: it exclusively populates the functional off-state but cannot switch to the on-state, regardless of the presence or absence of ligand. We show that only the combined matching of transcription rates and ligand binding enables transcription intermediates to undergo ligand-dependent conformational refolding.
Gene-modified autologous hematopoietic stem cells (HSC) can provide ample clinical benefits to subjects suffering from X-linked chronic granulomatous disease (X-CGD), a rare inherited immunodeficiency characterized by recurrent, often life-threatening bacterial and fungal infections. Here we report on the molecular and cellular events observed in two young adults with X-CGD treated by gene therapy in 2004. After the initial resolution of bacterial and fungal infections, both subjects showed silencing of transgene expression due to methylation of the viral promoter, and myelodysplasia with monosomy 7 as a result of insertional activation of ecotropic viral integration site 1 (EVI1). One subject died from overwhelming sepsis 27 months after gene therapy, whereas a second subject underwent an allogeneic HSC transplantation. Our data show that forced overexpression of EVI1 in human cells disrupts normal centrosome duplication, linking EVI1 activation to the development of genomic instability, monosomy 7 and clonal progression toward myelodysplasia.
SARS-CoV-2 contains a positive single-stranded RNA genome of approximately 30 000 nucleotides. Within this genome, 15 RNA elements were identified as conserved between SARS-CoV and SARS-CoV-2. By nuclear magnetic resonance (NMR) spectroscopy, we previously determined that these elements fold independently, in line with data from in vivo and ex-vivo structural probing experiments. These elements contain non-base-paired regions that potentially harbor ligand-binding pockets. Here, we performed an NMR-based screening of a poised fragment library of 768 compounds for binding to these RNAs, employing three different 1H-based 1D NMR binding assays. The screening identified common as well as RNA-element specific hits. The results allow selection of the most promising of the 15 RNA elements as putative drug targets. Based on the identified hits, we derive key functional units and groups in ligands for effective targeting of the RNA of SARS-CoV-2.
Throughout mankind’s history, the need to secure and protect the home settlement was an essential one. This holds especially true for the city of Ainos (modern Enez) in Turkish Thrace. Due to its continuous settlement history since the 7th/6th century BC, several different types of city walls were built—sometimes even on top of each other—several of which have been preserved over time. To decipher the construction style, the course and the age of a buried city wall segment in the southern part of the former city, a geoscientific multi-proxy approach including magnetic gradiometer (MG) and electrical resistivity tomography (ERT) measurements in combination with granulometrical, sedimentological and microfaunistical investigations on sediment cores was applied. We were able to (1) present reasonable arguments for its Hellenistic age; (2) reveal the course of this wall segment and extrapolate it further north into a less studied area; and (3) demonstrate that in this near-coastal area, the former swampy terrain had been consolidated for constructing the wall. Our multi-proxy approach serves as a valuable example for investigating buried structures in archaeological contexts, avoiding a less-economical, time-consuming, or even forbidden excavation.
We combined biostratigraphical analyses, archaeological surveys, and Glacial Isostatic Adjustment (GIA) models to provide new insights into the relative sea-level evolution in the northeastern Aegean Sea (eastern Mediterranean). In this area, characterized by a very complex tectonic pattern, we produced a new typology of sea-level index point, based on the foraminiferal associations found in transgressive marine facies. Our results agree with the sea-level history previously produced in this region, therefore confirming the validity of this new type of index point. The expanded dataset presented in this paper further demonstrates a continuous Holocene RSL rise in this portion of the Aegean Sea. Comparing the new RSL record with the available geophysical predictions of sea-level evolution indicates that the crustal subsidence of the Samothraki Plateau and the North Aegean Trough played a major role in controlling millennial-scale sea-level evolution in the area. This major subsidence rate needs to be taken into account in the preparation of local future scenarios of sea-level rise in the coming decades.